ADM and CJ CheilJedang launch joint venture for feed‑grade amino acids in the Americas
Archer‑Daniels‑Midland (ADM) and South Korean firm CJ CheilJedang agreed to create a new company that will produce and sell feed‑grade amino acids across North and South America. CJ will own the majority stake and will provide its fermentation technology, while ADM will contribute its Decatur, Illinois plant and its U.S. feedstock supply network. The venture will operate facilities in Iowa, Illinois and Brazil and will need regulatory clearance before it can start. Senior executives from both firms said the partnership is intended to improve cost competitiveness and support domestic production of amino acids such as lysine.
Why it matters
The joint venture consolidates a large portion of ADM’s amino‑acid exposure into a separate vehicle, which could affect how the company allocates capital and manages margins in its animal‑nutrition segment. Analysts note that the deal may help ADM sustain earnings growth, but the impact will depend on the JV’s execution and any regulatory approvals.
Key facts
- 1CJ CheilJedang will hold majority ownership of the new venture. tradingview.com
- 2The JV will use CJ’s production sites in Fort Dodge, Iowa, and Piracicaba, Brazil, together with ADM’s plant in Decatur, Illinois. investing.com
- 3CJ will license its fermentation technology for feed‑grade amino acids to the JV for use in North and South America. investing.com
- 4The launch date is subject to customary closing activities and regulatory approvals. investing.com
- 5Analysts project ADM revenue to grow 2.8% per year to US$89.2 billion by 2029, with earnings rising to US$2.3 billion. simplywall.st
Summary written by AlphAI from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.